After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

which has seen a significant boost in profits from Zepbound and Mounjaro — essentially the same drug with different FDA-approved uses — announced that the new vials and pricing are exclusively ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

As weight loss drugs continue to grow in popularity in the U.S., some health leaders are warning about fake drugs on the ...

Ignore the noise in GLP-1 stocks. Find the best value instead.

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Importantly, the single-dose vials need to be loaded into a syringe ... Lilly’s Zepbound and diabetes counterpart Mounjaro made it off the list last October and Novo’s semaglutide drugs ...

Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its ...